As aberrant IL‐6–JAK–STAT3 signaling is an important mechanism for cancer initiation, development, and progression [180], S1P/S1PR1 signaling accelerates tumor growth and metastasis via an IL‐6/JAK2‐mediated persistent activation of STAT3 [179]. Here, STAT3 is linked to cancer.